Maplight Therapeutics Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Maplight Therapeutics Inc 's ROA in the second quarter of 2026?
Maplight Therapeutics Inc recorded a cumulative net loss of $-121 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -31.72%.

However, within the Healthcare sector 435 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2026 from to 3607.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) III. Quarter
Y / Y Total Assets Change	74.37 %	-	-	-	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-121	-91	-52	-103	-92
Return On Assets (TTM)	-31.72 %	-26.49 %	-22.02 %	-87.8 %	-175.02 %
MPLT's Total Ranking	# 3607	#	#	#	#
Total Assets (TTM) in million	368	419	480	257	211
Seq. Total Assets Change	-12.04 %	-12.66 %	86.42 %	21.77 %	-
Seq. Net Income Change	-	-	-	-	-

MPLT's 5 Years Annual ROA >> Back to MPLT Management Effectiveness >> Compare MPLT ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 169
Sector	# 436
Overall	# 3640

Return On Assets Statistics
High	Average	Low
-28.01 %	-29.87 %	-31.72 %
(Mar 31 2026)		(Jun 30 2026)

Financial Statements
Maplight Therapeutics Inc 's Assets	$ 368 million	MPLT's Balance sheet
Maplight Therapeutics Inc 's Income	$ -60 million	Quarterly MPLT's Income Statement
MPLT's Income by Division		See MPLT's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	FY	FY	FY	FY
Y / Y Total Assets Change	-	-	-	-	-
Total Assets in million	628	0	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-161	0	0	0	0
Annual Return On Assets	-25.68 %	-	-	-	-

MPLT's 5 Years Annual ROA >> Back to MPLT Management Effectiveness >> Compare MPLT ROA to its Competitors

More Return On Assets Ratios
MPLT's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
MPLT's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for MPLT's Competitors
Subscribers only: Roa for Maplight Therapeutics Inc 's Suppliers
Subscribers only: Return On Assets for MPLT's Customers

You may also want to know
MPLT's Roi	MPLT's Inventory Turnover Ratio	MPLT's Growth Rates	MPLT's Dividend Comparisons
	MPLT's Profitability Ratios	MPLT's Asset Turnover Ratio	MPLT's Dividend Growth
MPLT's Roe	MPLT's Valuation Ratios	MPLT's Financial Strength Ratios	MPLT's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-26T07:43:40+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.